Sandoz Irbesartan Hct(2021-01-12)
Sandoz Irbesartan HCT Recall Sandoz is recalling Irbesartan HCT, a medication used to treat high blood pressure, across Canada due to a product safety issue. The recall is classified as Class I, the most serious type. This recall affects all Canadian consumers who have been prescribed this medication.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-01-12
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/2db26fb7-491d-4cdc-8f76-b141593ed881